C₁₅₂H₂₅₂N₄₄O₄₂
CJC-1295 (w/DAC)
Extended GHRH Analog
CJC-1295 with DAC uses Drug Affinity Complex technology to bind serum albumin, significantly extending its half-life. Research demonstrates sustained, dose-dependent increases in GH and IGF-1 levels with minimal effect on cortisol and prolactin.
Research Applications
- Sustained GH/IGF-1 elevation
- Extended half-life via DAC technology
- Dose-dependent response profile
- GHRH receptor pathway research
Purity
≥99%
Molecular Weight
3367.97 g/mol
Form
Lyophilized Powder
Storage
Store at -20°C. Protect from light.
Select Size
Quantity
Discount Code
Fulfillment Method
⚠ For Research Use Only
This product is intended strictly for in vitro laboratory research use only by qualified professionals. Not for human consumption. Not intended for diagnostic, therapeutic, or any in-vivo use in humans or animals. This product has not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease. Buyer is responsible for compliance with all applicable federal, state, and local laws including those of the State of Oklahoma. Must be 21+ to purchase. Full Research Disclaimer.